China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Sees Large Growth in Short Interest

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) was the recipient of a large increase in short interest in April. As of April 15th, there was short interest totalling 63,600 shares, an increase of 142.7% from the March 31st total of 26,200 shares. Based on an average daily trading volume, of 1,220,000 shares, the days-to-cover ratio is currently 0.1 days. Currently, 11.6% of the shares of the stock are sold short.

China SXT Pharmaceuticals Stock Performance

Shares of China SXT Pharmaceuticals stock traded up $0.02 on Friday, hitting $1.05. 203,439 shares of the company traded hands, compared to its average volume of 2,344,629. The firm’s 50-day simple moving average is $1.68 and its 200 day simple moving average is $2.01. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.41 and a current ratio of 1.47. China SXT Pharmaceuticals has a 12-month low of $0.94 and a 12-month high of $9.38.

China SXT Pharmaceuticals Company Profile

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.